2006 - KRN951, a highly potent and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has anti-tumor activities and affects functional vascular properties

K. Nakamura, E. Taguschi, T. Miura, A. Yamamoto, K. Takahashi, F. Bichat, N. Guilbaud, K. Hasegawa,
K. Kubo, Y. Fijuwara, R. Suzuki, K. Kubo, M. Shibuya and T. Isoe
Cancer Research 2006 Sep 15, 66(18): 9134-42

LEARN MORE

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.